GGrantIndex
Sort

1,049,261 grants matching t cell

Messenger RNA Immunogens for initiation of protective HIV non-neutralizing antibodies

$3,846,345
Barton F Haynes · Duke University · U19 · FY2021 · AI

Messenger RNA Immunogens for initiation of protective HIV non-neutralizing antibodies

$3,846,023
Barton F Haynes · Duke University · U19 · FY2024 · AI

Maintenance and Improvement of NINDS Infrastructure

$3,845,929
Rita Devine · National Institute Of Neurological Disorders And Stroke · ZIC · FY2021 · NS

Genetic Mechanisms in Pediatric Heart Disease

$3,845,641
Robert J Levy · Children'S Hosp Of Philadelphia · P50 · FY2007 · HL

Border Biomedical Research Center

$3,844,303
Robert Kirken · University Of Texas El Paso · G12 · FY2016 · MD

General Clinical Research Center

$3,843,856
Case Western Reserve University · M01 · FY2005 · RR

RESEARCH-PGR: Genomic and Synthetic Approaches Linking Auxin Signaling to Functional Domains in Maize

$3,843,077
Paula C McSteen · University Of Missouri-Columbia · · FY2016 · BIO

Project 3: Peribunyaviridae Pathogenesis and Vaccine Testing

$3,842,980
Shannon Ronca · University Of California-Irvine · U19 · FY2024 · AI

MPD Research Consortium

$3,842,401
Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2013 · CA

High Resolution Analysis of Env-directed B Cells to Accelerate Vaccine Design

$3,841,632
Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2016 · AI

Perturbing the LXR/SREBP axis to decipher protective and pathogenic AD/ADRD microglial phenotypes

$3,840,870
Christopher K Glass · University Of California, San Diego · RF1 · FY2024 · AG

Multicenter AIDS Cohort Study - Part B (Baltimore Center)

$3,840,029
Joseph B. Margolick · Johns Hopkins University · U01 · FY2011 · AI

NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial in patients with retinitis pigmentosa

$3,839,889
Xiangrong Kong · Johns Hopkins University · UG1 · FY2022 · EY

Facility Upgrade for the New England Regional Biosafety Laboratory

$3,839,739
Sam R. Telford · Tufts University Boston · G20 · FY2022 · AI

Signature-Directed, Sequential Delivery of Radiation Mitigators

$3,839,379
Joel S Greenberger · University Of Pittsburgh At Pittsburgh · U19 · FY2017 · AI

GENERAL CLINICAL RESEARCH CENTER

$3,839,211
New York University School Of Medicine · M01 · FY2001 · RR

DART2.0: comprehensive cell type-specific behavioral neuropharmacology

$3,838,425
Michael R Tadross · Duke University · RF1 · FY2018 · MH

Dissecting the role of FMRP in RNA processing using hPSC models

$3,837,790
Lindy Elise Barrett · Broad Institute, Inc. · R01 · FY2020 · HD

RII Track-2 FEC: Sensing and Educating the Nexus to Sustain Ecosystems (SENSE). A Kentucky-West Virginia Partnership

$3,837,645
David S White · Murray State University · · FY2016 · O/D

Reconfigurable 3D Origami Probes for Multi-modal Neural Interface

$3,837,586
Euisik Yoon · University Of Michigan At Ann Arbor · RF1 · FY2023 · NS

Strategies for Cancer Immunotherapy Development: Preclinical Studies

$3,837,391
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

SSCOR in Pediatric Heart Development and Disease

$3,836,294
Jane W. Newburger · Boston Children'S Hospital · P50 · FY2008 · HL

Tuberculosis Research Materials and Vaccine Testing

$3,836,004
Karen Dobos · Colorado State University · N01 · FY2011 · AI

ST JUDE CHILDRENS CANCER CENTER SUPPORT GRANT (CCSG)

$3,835,726
St. Jude Children'S Research Hospital · P30 · FY2000 · CA

LcrV Plague Vaccine with Altered Immune Modulatory Properties

$3,835,703
Olaf Schneewind · University Of Chicago · U01 · FY2008 · AI